(Q38194974)

30 August 2017

1 reference

title

Multiple system atrophy of the cerebellar type: clinical state of the art. (English)

1 reference

30 August 2017

main subject

multiple system atrophy

1 reference

3

Jeremy D Schmahmann

1 reference

30 August 2017

David J Lin

1

1 reference

30 August 2017

Katherine L Hermann

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

24 February 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

29

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

294-304

1 reference

Second consensus statement on the diagnosis of multiple system atrophy

30 August 2017

cites work

1 reference

Multiple system atrophy--the nature of the beast

21 January 2018

1 reference

Recent developments in multiple system atrophy.

21 January 2018

1 reference

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

21 January 2018

1 reference

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

21 January 2018

1 reference

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

The European Multiple System Atrophy-Study Group (EMSA-SG).

21 January 2018

1 reference

Potential outcome measures and trial design issues for multiple system atrophy

21 January 2018

1 reference

The North American Multiple System Atrophy Study Group

21 January 2018

1 reference

Parkinson's disease and parkinsonism: neuropathology

21 January 2018

1 reference

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

21 January 2018

1 reference

Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy

21 January 2018

1 reference

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

Alpha-synuclein and neurodegenerative diseases

21 January 2018

1 reference

Parkinson's disease and other alpha-synucleinopathies

21 January 2018

1 reference

Consensus statement on the diagnosis of multiple system atrophy.

21 January 2018

1 reference

Multiplex families with multiple system atrophy

21 January 2018

1 reference

Definite multiple system atrophy in a German family.

21 January 2018

1 reference

Probable hereditary multiple system atrophy-autonomic (MSA-A) in a family in the United States.

21 January 2018

1 reference

Mutations in COQ2 in familial and sporadic multiple-system atrophy

21 January 2018

1 reference

Sporadic ataxia with adult onset: classification and diagnostic criteria

21 January 2018

1 reference

Paraneoplastic movement disorders

21 January 2018

1 reference

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

21 January 2018

1 reference

Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia

21 January 2018

1 reference

Prevalence of antigliadin antibodies in ataxia patients

21 January 2018

1 reference

Acute cerebellar ataxia due to Epstein-Barr virus

21 January 2018

1 reference

Case records of the Massachusetts General Hospital. Case 30-2013. A 19-year-old man with otalgia, slurred speech, and ataxia

21 January 2018

1 reference

Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration

21 January 2018

1 reference

Acute-onset cerebellar symptoms in Lhermitte-Duclos disease: case report

21 January 2018

1 reference

Superficial siderosis of the central nervous system.

21 January 2018

1 reference

Cognitive and social impairments in patients with superficial siderosis

21 January 2018

1 reference

Brain pathology of spinocerebellar ataxias

21 January 2018

1 reference

Nonmotor and extracerebellar features in Machado-Joseph disease: a review.

21 January 2018

1 reference

Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives

21 January 2018

1 reference

Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

21 January 2018

1 reference

Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates

21 January 2018

1 reference

The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group

21 January 2018

1 reference

Friedreich's ataxia: pathology, pathogenesis, and molecular genetics

21 January 2018

1 reference

Olivopontocerebellar atrophy: toward a better nosological definition

21 January 2018

1 reference

Clinical and genetic study of autosomal recessive cerebellar ataxia type 1.

21 January 2018

1 reference

Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients

21 January 2018

1 reference

Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination

21 January 2018

1 reference

Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome

21 January 2018

1 reference

Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease

21 January 2018

1 reference

The aetiology of sporadic adult-onset ataxia

21 January 2018

1 reference

Late-onset pure cerebellar ataxia: differentiating those with and without identifiable mutations

21 January 2018

1 reference

FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia.

21 January 2018

1 reference

The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study.

21 January 2018

1 reference

Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology

21 January 2018

1 reference

Magnetic resonance imaging in hereditary and idiopathic ataxia.

21 January 2018

1 reference

Population based study of late onset cerebellar ataxia in south east Wales.

21 January 2018

1 reference

Distribution of cerebello-olivary degeneration in idiopathic late cortical cerebellar atrophy: clinicopathological study of four autopsy cases

21 January 2018

1 reference

Sporadic adult onset ataxia of unknown etiology : a clinical, electrophysiological and imaging study

21 January 2018

1 reference

Olivopontocerebellar atrophy. A review of 117 cases

21 January 2018

1 reference

MRI-based volumetric differentiation of sporadic cerebellar ataxia.

21 January 2018

1 reference

Cerebellar presentation of multiple system atrophy

21 January 2018

1 reference

When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study

21 January 2018

1 reference

Sphincter EMG and differential diagnosis of multiple system atrophy

21 January 2018

1 reference

Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations

21 January 2018

1 reference

Sphincter EMG as a diagnostic tool in autonomic disorders

21 January 2018

1 reference

Clinical and magnetic resonance imaging characteristics of sporadic cerebellar ataxia.

21 January 2018

1 reference

Nonmotor presentations of multiple system atrophy

21 January 2018

1 reference

Premotor signs and symptoms of multiple system atrophy

21 January 2018

1 reference

Magnetic resonance and nuclear medicine imaging in ataxias

21 January 2018

1 reference

Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

21 January 2018

1 reference

Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy

21 January 2018

1 reference

Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes.

21 January 2018

1 reference

Clinical usefulness of magnetic resonance imaging in multiple system atrophy

21 January 2018

1 reference

"Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging.

21 January 2018

1 reference

Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA).

21 January 2018

1 reference

The 'hot cross bun' sign in the patients with spinocerebellar ataxia.

21 January 2018

1 reference

Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?

21 January 2018

1 reference

How to diagnose MSA early: the role of magnetic resonance imaging

21 January 2018

1 reference

Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.

21 January 2018

1 reference

Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy

21 January 2018

1 reference

Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy

21 January 2018

1 reference

Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia

21 January 2018

1 reference

Multiple system atrophy: an update.

21 January 2018

1 reference

Multiple system atrophy: a clinical and neuropathological perspective

21 January 2018

1 reference

Management of multiple system atrophy: state of the art.

21 January 2018

1 reference

The dopaminergic response in multiple system atrophy

21 January 2018

1 reference

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

21 January 2018

1 reference

The natural history of multiple system atrophy: a prospective European cohort study

21 January 2018

1 reference

Dystonia in multiple system atrophy

21 January 2018

1 reference

Management of neurogenic orthostatic hypotension: an update

21 January 2018

1 reference

Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group

21 January 2018

1 reference

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.

21 January 2018

1 reference

L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure

21 January 2018

1 reference

Norepinephrine precursor therapy in neurogenic orthostatic hypotension

21 January 2018

1 reference

Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration

21 January 2018

1 reference

No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).

21 January 2018

1 reference

A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis

21 January 2018

1 reference

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

21 January 2018

1 reference

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes

21 January 2018

1 reference

Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors

21 January 2018

1 reference

Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

21 January 2018

1 reference

Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy

21 January 2018

1 reference

Rasagiline is neuroprotective in a transgenic model of multiple system atrophy

21 January 2018

1 reference

Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy

21 January 2018

1 reference

Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection

21 January 2018

1 reference

Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.

21 January 2018

1 reference

A randomized trial of mesenchymal stem cells in multiple system atrophy.

21 January 2018

1 reference

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

21 January 2018

1 reference

Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.

21 January 2018

1 reference

α-Synuclein: membrane interactions and toxicity in Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25847

1 reference

30 August 2017

1 reference